5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α -glucosidase and urease enzymes-Reference-Cited by-同舟云学术

5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α -glucosidase and urease enzymes

Published:2017-06 Issue: Volume:72 Page:21-31
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Arshad Tanzila,Khan Khalid Mohammed,Rasool Najma,Salar Uzma,Hussain Shafqat,Asghar Humna,Ashraf Mohammed,Wadood Abdul,Riaz Muhammad,Perveen Shahnaz,Taha Muhammad,Ismail Nor Hadiani

Funder

Higher Education Commission

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference29 articles.

1. Leaf Urea Metabolism in Potato. Urease Activity Profile and Patterns of Recovery and Distribution of 15N after Foliar Urea Application in Wild-Type and Urease-Antisense Transgenics

2. Structural properties of the nickel ions in urease: novel insights into the catalytic and inhibition mechanisms

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on the Development of Novel Heterocycles as α-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus;Medicinal Chemistry;2024-06

2. Cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, biological analysis and molecular docking study of sulphur containing heterocyclic analogues;Chemical Data Collections;2024-06

3. Design and discovery of urease and Helicobacter pylori inhibitors based on benzofuran/benzothiophene-sulfonate and sulfamate scaffolds for the treatment of ureolytic bacterial infections;International Journal of Biological Macromolecules;2024-06

4. New piperidinyl heterocyclic azoles acquired through Li(I)-catalyzed reactions: Anti-enzymatic, ADME and computational studies;Journal of Molecular Structure;2024-04

5. Antiurease Activity of Antibiotics: In Vitro, In Silico, Structure Activity Relationship, and MD Simulations of Cephalosporins and Fluoroquinolones;ACS Omega;2024-03-14